Inactive Instrument

CBD Global Sciences Stock

Equities

CBDN

CA12482U1057

Dynamic Chart
CBD Global Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
CBD Global Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
CBD Global Sciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
CBD Global Sciences Inc. Auditor Raises 'Going Concern' Doubt CI
CBD Global Sciences Inc. cancelled the acquisition of Pure BioPlastics Inc. CI
CBD Global Sciences Inc. Announces Change of Chief Financial Officer CI
CBD Global Sciences Inc. Appoints Ed Lehrburger to the Board of Directors CI
CBD Global Sciences Inc. announced that it has received $0.085 million in funding CI
CBD Global Sciences Inc. executed a binding letter of intent to acquire Pure BioPlastics Inc. CI
CBD Global Sciences Inc. announced that it expects to receive $0.085 million in funding CI
CBD Global Sciences, Inc. Announces the Successful Launch of Rap Snacks in the Colorado Market That Exceeded First Week Sales Expectations CI
CBD Global Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
CBD Global Sciences, Inc. Approves the Appointment of Jeff Hays to the Board of Directors CI
CBD Global Sciences Inc. completed the acquisition of Resinosa LLC. CI
CBD Global Sciences Inc. executed a definitive agreement to acquire Resinosa LLC. CI
More news
Managers TitleAgeSince
Founder 55 18-08-29
Founder 55 18-08-29
Director/Board Member - -
Members of the board TitleAgeSince
Founder 55 18-08-29
Founder 55 18-08-29
Director/Board Member - -
More insiders
CBD Global Sciences Inc. is a Canada-based cannabidiol (CBD) producer. The Company is engaged in the business of producing and selling industrial hemp derived CBD infused consumable and topical products, including CBD oil tincture drops, CBD hydration beverages, and CBD topicals. It markets and sells its own brand of CBD oil and byproducts under the Aethics and CannaOil brands (Products), which includes CBD Oil tinctures (liquid products), capsules, topicals, hydration products and confectionary products. Its hemp-derived CBD extracts are sold through distributors, brick and mortar retailers and online. The Company, through its subsidiaries, Global Sciences Holdings, Resinosa LLC and Legacy Distribution Group, is delivering CBD products both in retail and e-commerce formats. It also operates a manufacturing division, Resinosa LLC, with its capabilities to provide current good manufacturing practices (cGMP) to the CBD industry with both private label and white label CBD product lines.
Sector
-
More about the company